Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies

News

News updates: Subscribe
Unsubscribe

Archive

July 22, 2008
LCT Reports Clinical Benefits
>more
July 17, 2008
LCT Hosts Seminar of World Leaders
>more
July 14, 2008
LCT Quarterly Newsletter
>more
July 11, 2008
Transcript of LCT interview with The Wall Street
>more
June 26, 2008
LCT Informed of Progress for Diabetes Clinical Trial
>more
 

News

LCT Investor Update - October 2006
October 2, 2006

This monthly update is to help explain the current business and research activities undertaken by Living Cell Technologies and the progression of its lead products to market. In this edition, it includes:
- Year end financial results
- Key milestones achieved
- Industry update

Related Document
Download ( = 123Kb )

LCT - Living Cell Technologies

Q & A

What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors. >more
 
HomeContactSitemapLegalsPrivacy
  
graphic design and website design - PDF Communications Ltd